Pay in 4 interest-free payments of $7.28 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Formula: Concentration = Vial mg / Water mL
Sever et al., 2019) or continuous alcohol consumption (Prkacin et al., 2001)
Dosing Comparison# BPC-157 Dosing# In preclinical research, BPC-157 has been studied across a range of administration routes: Subcutaneous injection : Typical research doses range from 200-800 mcg/day in human-equivalent calculations Oral administration : BPC-157 shows stability in gastric acid, with studies demonstrating oral bioavailability Local injection : Site-specific injection near injury areas has been used in tendon and ligament studies Intraperitoneal : Common route in rodent studies at doses of 10 mcg/kg to 10 ng/kg BPC-157 is typically reconstituted from lyophilized powder with bacteriostatic water for injection protocols
Gastrointestinal Research Because of its origin in gastric tissue, BPC-157 is evaluated for potential effects on: Gastrointestinal mucosal protection Ulcer models Intestinal barrier support Inflammatory modulation in GI tissue 4
July 23-24, 2026: Meeting of the Pharmacy Compounding Advisory Committee BPC-157, KPV, TB-500, and MOTs-C bulk drug substances
US$ 24.16
US$ 23.68
US$ 22.96
US$ 23.95
US$ 23.46
